Unknown PHASE2 INTERVENTIONAL 4-arm NCT01617772

Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis (NALCAT)

Comparison the Effectiveness of L-Carnitine With Atorvastatin in Non-Alcoholic Steatohepatitis (NASH)

Sponsor: Tehran University of Medical Sciences

Conditions Non-alcoholic Steatohepatitis

Interventions Atorvastatin L-Carnitine Placebo

Updated 8 times since 2017 Last updated: May 5, 2018 Started: Jan 1, 2016 Primary completion: Oct 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Non-alcoholic Steatohepatitis, this trial is ongoing. The trial is conducted by Tehran University of Medical Sciences and has accumulated 8 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jun 2020 [monthly]

Recruiting PHASE2
Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE2

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tehran University of Medical Sciences

Data source: Tehran University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shiraz, Iran
• Tehran, Iran